ATE359770T1 - Antipyretisches präparat enhaltend xylitol - Google Patents

Antipyretisches präparat enhaltend xylitol

Info

Publication number
ATE359770T1
ATE359770T1 AT02292961T AT02292961T ATE359770T1 AT E359770 T1 ATE359770 T1 AT E359770T1 AT 02292961 T AT02292961 T AT 02292961T AT 02292961 T AT02292961 T AT 02292961T AT E359770 T1 ATE359770 T1 AT E359770T1
Authority
AT
Austria
Prior art keywords
preparation containing
antipyretic
containing xylitol
antipyretic preparation
xylitol
Prior art date
Application number
AT02292961T
Other languages
English (en)
Inventor
Daniel Wils
Roselyne Bernard
Original Assignee
Roquette Freres
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roquette Freres filed Critical Roquette Freres
Application granted granted Critical
Publication of ATE359770T1 publication Critical patent/ATE359770T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02292961T 2001-12-10 2002-12-02 Antipyretisches präparat enhaltend xylitol ATE359770T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0115917A FR2833173B1 (fr) 2001-12-10 2001-12-10 Preparation antipyretique renfermant du xylitol

Publications (1)

Publication Number Publication Date
ATE359770T1 true ATE359770T1 (de) 2007-05-15

Family

ID=8870281

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02292961T ATE359770T1 (de) 2001-12-10 2002-12-02 Antipyretisches präparat enhaltend xylitol

Country Status (10)

Country Link
US (2) US20030109565A1 (de)
EP (1) EP1317922B1 (de)
JP (1) JP2003171266A (de)
CN (1) CN1432357A (de)
AT (1) ATE359770T1 (de)
CA (1) CA2413024A1 (de)
DE (1) DE60219578D1 (de)
FR (1) FR2833173B1 (de)
MX (1) MXPA02012232A (de)
NO (1) NO20025901L (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070048356A1 (en) * 2005-08-31 2007-03-01 Schorr Phillip A Antimicrobial treatment of nonwoven materials for infection control
US20070048358A1 (en) * 2005-08-31 2007-03-01 Schorr Phillip A Antimicrobial substrates
US20070048344A1 (en) * 2005-08-31 2007-03-01 Ali Yahiaoui Antimicrobial composition
JP2008266203A (ja) * 2007-04-19 2008-11-06 Bussan Food Science Kk 活性酸素種消去酵素群の活性を向上させる方法
IL206739A (en) 2010-06-30 2016-06-30 David Segal An injectable drug containing silitol as an active substance

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2833M (de) * 1962-06-12 1964-10-05 I N I C O Ind Nuclear Invest C
GB1212115A (en) * 1967-11-29 1970-11-11 Far Eastern Detailers Ltd Pharmaceutical composition comprising magnesium acetylsalicylate and method for preparing same
DE4102629A1 (de) * 1991-01-30 1992-08-06 Bayer Ag Pharmazeutischer kaugummi mit acetylsalicylsaeure
US5331000A (en) * 1992-03-09 1994-07-19 Sepracor Inc. Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen
TR199802068T2 (xx) * 1996-04-16 2000-01-21 Novartis Consumer Health S.A. H�zl� b�l�nen oral doz formu.
US5719196A (en) * 1996-07-24 1998-02-17 Leiras Oy Method of treating respiratory infections or complications derived therefrom in humans which includes oral administration of xylitol
US6270790B1 (en) * 1998-08-18 2001-08-07 Mxneil-Ppc, Inc. Soft, convex shaped chewable tablets having reduced friability
US6447754B1 (en) * 2000-01-24 2002-09-10 Akpharma Inc. Oral rinse methods and compositions

Also Published As

Publication number Publication date
JP2003171266A (ja) 2003-06-17
NO20025901L (no) 2003-06-11
EP1317922A1 (de) 2003-06-11
US20030109565A1 (en) 2003-06-12
MXPA02012232A (es) 2005-06-06
EP1317922B1 (de) 2007-04-18
CA2413024A1 (fr) 2003-06-10
DE60219578D1 (de) 2007-05-31
FR2833173B1 (fr) 2004-08-27
NO20025901D0 (no) 2002-12-09
FR2833173A1 (fr) 2003-06-13
CN1432357A (zh) 2003-07-30
US20060142254A1 (en) 2006-06-29

Similar Documents

Publication Publication Date Title
PT1073470E (pt) Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos
ITRM920361A1 (it) Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo.
NO20041270D0 (no) Farmasoytiske sammensetninger som innbefatter kolloidal silikondioksid
DE60205870D1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
NO2011026I2 (no) Eribulin eller et farmasøytisk akseptabelt salt derav
PL410219A1 (pl) Kompozycja zawierająca koniugat leku obejmujący pochodne kalicheamycyny i przeciwciało, oraz kompozycja farmaceutyczna ją zawierająca
YU23599A (sh) Stabilizovani antihistaminski sirup
CA2414018A1 (en) 2-aminocarbonyl-9h-purine derivatives
MXPA02009773A (es) Derivados de indolin-2-ona y su uso como ligandos de receptores de ocitocina.
DE60218885D1 (de) Orale pharmazeutische zusammensetzungen mit verzögerter freisetzung enthaltend 5,8,14-triazatetracyclo (10.3.1.0(2,11) 0 (4,9) )-hexadeca-2(11) 3, 5,7, 9-pentaene
EP2266622A3 (de) Prodrugs mit neuen biospaltbaren Verbindern
BR9810658A (pt) Composições farmacêuticas contendo hemissulfato de eletriptano e cafeìna.
HK1155146A1 (zh) 作為藥物活性劑的茚衍生物
DK1121127T3 (da) Orale farmaceutiske sammensætninger, som indeholder buprenorphin
BR0212353A (pt) Composto, composição farmacêutica, e, uso de um composto
NO20034527D0 (no) 3,7-diazabicyklo(3,3,1) formuleringer som antiarytmiforbindelser
CO5580729A2 (es) Composiciones nutricionales que comprenden cistationina
EP1607097A3 (de) Stabilisierte zusammensetzungen die sauerstoffempfindliche Verbindungen enthalten
ATE359770T1 (de) Antipyretisches präparat enhaltend xylitol
BR9915692A (pt) Monohidrato de bromidrato de eletriptano
DE69928646D1 (de) Derivate des streptogramins, ihre herstellung und sie enthaltende zubereitungen
CA2442210A1 (en) Aryl oxime-piperazines useful as ccr5 antagonists
DE60001366D1 (de) Orale zusammensetzung enthaltend perlit
DE50213012D1 (de) Polyamide-zusammensetzungen enthaltend antioxidantien
NO20034529D0 (no) 3,7-diazabicyklo(3,3,1) formuleringer samt antiarytmiforbindelser

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties